Ethosuximide, Urine
Ethosuximide is classified as an anticonvulsant drug and used to treat absence seizures characterized by brief loss of conciousness. The class of drugs known as anticonvulsants are designed to help the physician in treating patients with seizures. The most common type of seizure that the physician encounters in clinical medicine are epileptic seizures. Basically a seizure is an abnormal, excessive firing of neurons in the gray matter of the brain. Epilepsy is a disease of the brain in which an individual experiences recurrent seizures. Children may develop seizures as a result of a fever, known as febrile seizures.
The specific type of seizures that ethosuximide is used to treat are absence seizures, but not effective in the treatment of motor seizures. Ethosuximide is metabolized by hydroxylation of the parent drug. The use of this particular anticonvulsant has been decreased with the development of valproic acid. Overdose effects include shallow respiration, clammy skin, dilated pupils, weak and rapid pulse, coma, and possible death.
Ethosuximide can be analyzed by a variety of analytical methods such as Gas Chromatography/Mass spectroscopy (GC/MS), Liquid Chromatography/Mass Spectroscopy (LC/MS), Immunoassay, and screening spot testing.
- Therapeutic monitoring
- Drug abuse evaluation
- Toxicity assessment
- Patient Compliance
Therapeutic level: 40-100 mg/L
Toxic level: > 150 mg/L
Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.
Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.
Urine
Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.
Stability
- Ambient: 3-5 days
- Refrigerated: 5-7 days
- Frozen: 30 days
- Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Lettleton, MA: PSG Publisging Co.; 1987
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Seal Beach, CA: Biomedical Publications; 2011.
- Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Foster City, CA: Biomedical Publications; 2002.
- Gupta RN. Review: drug level monitoring: sedative hypnotics. J Chromatogr. 1985;340:139-72.
- Levine B (ed). Principles of Forensic Toxicology, 4th ed. Washington DC: AACC Press. Chapter 22, Anticonvulants and Antiarrhythmics, pp. 391-402; 2013.